Here is the latest financial fact sheet of SUN PHARMA ADV. RES.. For more details, see the SUN PHARMA ADV. RES. quarterly results and SUN PHARMA ADV. RES. share price.
1 Day | % | -5.0 |
No. of shares | m | 324.52 |
1 Week | % | -22.6 |
1 Month | % | -22.3 |
1 Year | % | 45.6 |
52 week H/L | Rs | 474.0/178.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SUN PHARMA ADV. RES. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 438 | 211 | 210 | 349 | 306 | |
Low | Rs | 141 | 81 | 95 | 142 | 161 | |
Sales per share (Unadj.) | Rs | 7.0 | 2.9 | 9.7 | 5.0 | 7.4 | |
Earnings per share (Unadj.) | Rs | -5.5 | -11.9 | -5.8 | -7.5 | -6.9 | |
Diluted earnings per share | Rs | -4.5 | -9.6 | -4.7 | -6.3 | -6.9 | |
Cash flow per share (Unadj.) | Rs | -5.3 | -11.6 | -5.4 | -7.1 | -6.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 11.3 | -0.7 | -6.4 | -7.5 | 15.8 | |
Adj. book value per share | Rs | 9.1 | -0.6 | -5.2 | -6.3 | 15.8 | |
Shares outstanding (eoy) | m | 262.05 | 262.05 | 262.05 | 271.88 | 324.52 | |
Price / Sales ratio | x | 41.5 | 49.8 | 15.8 | 48.6 | 31.7 | |
Avg P/E ratio | x | -52.2 | -12.2 | -26.4 | -32.8 | -34.0 | |
P/CF ratio (eoy) | x | -55.0 | -12.6 | -28.4 | -34.6 | -35.9 | |
Price / Book Value ratio | x | 25.6 | -205.1 | -23.7 | -32.9 | 14.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 75,889 | 38,220 | 39,871 | 66,767 | 75,630 | |
Total wages/salary | Rs m | 811 | 931 | 916 | 983 | 1,070 |
SUN PHARMA ADV. RES. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,829 | 768 | 2,530 | 1,372 | 2,388 | |
Other income | Rs m | 135 | 98 | 54 | 68 | 109 | |
Total revenues | Rs m | 1,964 | 866 | 2,584 | 1,441 | 2,497 | |
Gross profit | Rs m | -1,513 | -3,100 | -1,350 | -1,867 | -2,141 | |
Depreciation | Rs m | 76 | 95 | 109 | 102 | 118 | |
Interest | Rs m | 1 | 27 | 107 | 133 | 76 | |
Profit before tax | Rs m | -1,454 | -3,124 | -1,511 | -2,034 | -2,226 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -1,454 | -3,124 | -1,511 | -2,034 | -2,226 | |
Gross profit margin | % | -82.7 | -403.6 | -53.4 | -136.1 | -89.6 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | -79.5 | -406.7 | -59.7 | -148.2 | -93.2 |
SUN PHARMA ADV. RES. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,574 | 672 | 598 | 712 | 4,550 | |
Current liabilities | Rs m | 950 | 2,354 | 2,334 | 1,714 | 1,789 | |
Net working cap to sales | % | 88.8 | -218.9 | -68.6 | -73.1 | 115.6 | |
Current ratio | x | 2.7 | 0.3 | 0.3 | 0.4 | 2.5 | |
Inventory Days | Days | 539 | 370 | 111 | 272 | 815 | |
Debtors Days | Days | 203 | 762 | 254 | 738 | 500 | |
Net fixed assets | Rs m | 1,411 | 2,054 | 1,666 | 2,089 | 3,752 | |
Share capital | Rs m | 262 | 262 | 262 | 272 | 325 | |
"Free" reserves | Rs m | 2,700 | -448 | -1,945 | -2,302 | 4,803 | |
Net worth | Rs m | 2,962 | -186 | -1,683 | -2,030 | 5,128 | |
Long term debt | Rs m | 11 | 64 | 1,125 | 0 | 0 | |
Total assets | Rs m | 3,985 | 2,726 | 2,297 | 2,801 | 8,301 | |
Interest coverage | x | -1,546.1 | -115.8 | -13.2 | -14.3 | -28.2 | |
Debt to equity ratio | x | 0 | -0.3 | -0.7 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.3 | 1.1 | 0.5 | 0.3 | |
Return on assets | % | -36.5 | -113.6 | -61.2 | -67.9 | -25.9 | |
Return on equity | % | -49.1 | 1,676.2 | 89.8 | 100.2 | -43.4 | |
Return on capital | % | -48.9 | 2,526.3 | 252.0 | 93.6 | -41.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1,357 | 72 | 120 | 50 | 1,317 | |
Fx outflow | Rs m | 1,942 | 2,277 | 2,141 | 2,712 | 2,662 | |
Net fx | Rs m | -585 | -2,205 | -2,021 | -2,662 | -1,345 |
SUN PHARMA ADV. RES. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -1,719 | -2,108 | -1,519 | -2,082 | -691 | |
From Investments | Rs m | -1,022 | 1,553 | 16 | -292 | -5,483 | |
From Financial Activity | Rs m | 2,742 | 555 | 1,593 | 2,293 | 6,168 | |
Net Cashflow | Rs m | 1 | 0 | 90 | -81 | -6 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
YEAR OF INC: 2006 | BSE CODE: 532872 | FV (Rs): 1 | DIV YIELD (%): - |
Read: SUN PHARMA ADV. RES. 2022-23 Annual Report Analysis
More Business Support Company Fact Sheets: ZOMATO ADANI ENTERPRISES ADANI PORTS & SEZ APOLLO HOSPITALS ADANI TOTAL GAS
Compare SUN PHARMA ADV. RES. With: ZOMATO ADANI ENTERPRISES ADANI PORTS & SEZ APOLLO HOSPITALS ADANI TOTAL GAS
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.